Myriad Genetics Inc (LTS:0K3W)

$ 13.635 0.293 (2.19%) Market Cap: 1.24 Bil Enterprise Value: 1.29 Bil PE Ratio: 0 PB Ratio: 1.70 GF Score: 63/100

Q3 2024 Myriad Genetics Inc Earnings Call Transcript
Nov 07, 2024

$17.95 (+1.13%)

Earnings
Q2 2024 Myriad Genetics Inc Earnings Call Transcript
Aug 06, 2024

$26.48 (+4.85%)

Earnings
Q1 2024 Myriad Genetics Inc Earnings Call Transcript
May 07, 2024

$19.77 (+6.69%)

Earnings
Q4 2023 Myriad Genetics Inc Earnings Call Transcript
Feb 27, 2024

$23.49 (+3.60%)

Earnings
Myriad Genetics Inc at JPMorgan Healthcare Conference Transcript
Jan 11, 2024
Q3 2023 Myriad Genetics Inc Earnings Call Transcript
Nov 06, 2023

$16.98

Earnings
Myriad Genetics Inc Investor Day Transcript
Sep 19, 2023
Myriad Genetics Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 13, 2023
Q2 2023 Myriad Genetics Inc Earnings Call Transcript
Aug 03, 2023

$21.48

Earnings
Myriad Genetics Inc at Goldman Sachs Healthcare Conference Transcript
Jun 13, 2023
Myriad Genetics Inc at Bank of America Global Healthcare Conference Transcript
May 09, 2023
Q1 2023 Myriad Genetics Inc Earnings Call Transcript
May 03, 2023

$21.63 (+1.11%)

Earnings
Q4 2022 Myriad Genetics Inc Earnings Call Transcript
Feb 28, 2023

$18.72

Earnings
Myriad Genetics Inc at JPMorgan Healthcare Conference Transcript
Jan 10, 2023
Q3 2022 Myriad Genetics Inc Earnings Call Transcript
Nov 01, 2022

$19.01 (-6.88%)

Earnings
Myriad Genetics Inc Investor Day Transcript
Aug 11, 2022
Q2 2022 Myriad Genetics Inc Earnings Call Transcript
Aug 04, 2022

$25.35

Earnings
Myriad Genetics Inc at Bank of America Healthcare Conference Transcript
May 11, 2022
Q1 2022 Myriad Genetics Inc Earnings Call Transcript
May 05, 2022

$23.39

Earnings
Q4 2021 Myriad Genetics Inc Earnings Call Transcript
Feb 24, 2022

$30.89

Earnings
Myriad Genetics Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 11, 2022
Q3 2021 Myriad Genetics Inc Earnings Call Transcript
Nov 02, 2021

$30.89

Earnings
Q2 2021 Myriad Genetics Inc Earnings Call Transcript
Aug 03, 2021

$34.94 (+13.28%)

Earnings
Myriad Genetics Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Jun 10, 2021
Myriad Genetics Inc Annual Shareholders Meeting Transcript
Jun 03, 2021
Myriad Genetics Inc at Bank of America Global Research Healthcare Conference (Virtual) Transcript
May 12, 2021
Myriad Genetics Inc Virtual Investor Day Transcript
May 04, 2021
Castle Biosciences Inc to Acquire Myriad myPath® Laboratory Transcript
Apr 27, 2021
Q2 2021 Myriad Genetics Inc Earnings Call Transcript
Feb 23, 2021

$28.55 (-1.38%)

Earnings
Myriad Genetics Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 11, 2021
Myriad Genetics Inc Annual Shareholders Meeting Transcript
Dec 04, 2020
Q1 2021 Myriad Genetics Inc Earnings Call Transcript
Nov 09, 2020

$12.3

Earnings
Q4 2020 Myriad Genetics Inc Earnings Call Transcript
Aug 13, 2020

$29.06

Earnings
Q3 2020 Myriad Genetics Inc Earnings Call Transcript
May 05, 2020

$29.06

Earnings
Q2 2020 Myriad Genetics Inc Earnings Call Transcript
Feb 06, 2020

$29.06

Earnings
Myriad Genetics Inc at JPMorgan Healthcare Conference Transcript
Jan 13, 2020
Q1 2020 Myriad Genetics Inc Earnings Call Transcript
Nov 04, 2019

$32.02

Earnings
Myriad Genetics Inc at Morgan Stanley Healthcare Conference Transcript
Sep 10, 2019
Q4 2019 Myriad Genetics Inc Earnings Call Transcript
Aug 13, 2019

$45.1

Earnings
Myriad Genetics Inc at Goldman Sachs Global Healthcare Conference Transcript
Jun 11, 2019
Myriad Genetics Inc at UBS Global Healthcare Conference Transcript
May 21, 2019
Myriad Genetics Inc at Bank of America Merrill Lynch Health Care Conference Transcript
May 15, 2019
Q3 2019 Myriad Genetics Inc Earnings Call Transcript
May 07, 2019

$33.1

Earnings
Myriad Genetics Inc at Cowen Health Care Conference Transcript
Mar 12, 2019

Q2 2022 Myriad Genetics Inc Earnings Call Transcript

Aug 04, 2022 / 08:30PM GMT

Release Date Price: $25.35

Transcript 10-Q8-K

Operator

Greetings, and welcome to the Myriad Genetics Second Quarter 2022 Financial Earnings Conference Call. (Operator Instructions) As a reminder, this conference is being recorded today, Thursday, August 4, 2022.

I would now like to turn the conference over to Foster Harris. Please go ahead.

Foster Harris

Thank you. Good afternoon, and welcome to the Myriad Genetics' Second Quarter 2022 Earnings Call. On the call, we will review the financial results we released today and afterwards, we'll host a Q&A session.

Our quarterly earnings release was issued this morning on Form 8-K and can be found on our website at investor.myriad.com. I'm Foster Harris, Senior Associate of Investor Relations. On the call with me today are Paul Diaz, our President and Chief Executive Officer; Bryan Riggsbee, our Chief Financial Officer; and Nicole Lambert, our Chief Operating Officer. This call can be heard live via webcast at investor.myriad.com, and a recording will be archived in the Investors section of our website, along with this slide presentation.

Please

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.